Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Atrial Fibrillation : from pathophysiology to therapy

Identifieur interne : 000033 ( Hal/Corpus ); précédent : 000032; suivant : 000034

Atrial Fibrillation : from pathophysiology to therapy

Auteurs : Pedro Raphaël Martins

Source :

RBID : Hal:tel-01156546

Descripteurs français

English descriptors

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia, significantly increasing patients’ morbidity and mortality. The mechanisms explaining the initiation and maintenance of the arrhythmia are incompletely understood, and the current treatment strategy is suboptimal. To better understand the pathophysiology of AF, we conducted various projects using Langendorff-perfused sheep hearts and a chronic model of long-standing persistent AF. In the model of persistent AF, we demonstrated that dominant frequency (DF) progressively increases during the first weeks of the arrhythmia, during its paroxysmal stage, due to the electrophysiological remodeling resulting in atrial action potential shortening. DF stabilizes once the electrophysiological remodeling is maximal, and the arrhythmia becomes persitent. The rate of DF increase (dDF/dt) was strongly correlated with the time to persistent AF. Structural remodeling appears secondarily, once transition has occured. We also studied the anti-arrhythmic mechanisms of chloroquine (IK1 blocker) and ranolazine (INa blocker), which slow the frequency of rotation of rotors, decrease the DF and favor reversal to sinus rhythm. These projects helped us to better understand the importance of these currents in AF dynamics. Lastly, we demonstrated the increased efficacy of AF ablation when using the second generation cryoballoon (CB), which regrettably increases the occurrence of phrenic nerve palsy. A simple, reliable predictor of this complication was found, the distance between the lateral edge of the CB and the phrenic nerve stimulating catheter. A better understanding of the mechanisms underlying the initiation and maintenance of AF, in conjunction with better therapeutic strategies will help to improve patients’ quality of life and decrease the complications of the arrhythmia.


Url:

Links to Exploration step

Hal:tel-01156546

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Atrial Fibrillation : from pathophysiology to therapy</title>
<title xml:lang="fr">Fibrillation atriale : des mécanismes physiopathologiques à la prise en charge thérapeutique</title>
<author>
<name sortKey="Martins, Pedro Raphael" sort="Martins, Pedro Raphael" uniqKey="Martins P" first="Pedro Raphaël" last="Martins">Pedro Raphaël Martins</name>
<affiliation>
<hal:affiliation type="laboratory" xml:id="struct-182223" status="VALID">
<orgName>Laboratoire Traitement du Signal et de l'Image</orgName>
<orgName type="acronym">LTSI</orgName>
<desc>
<address>
<addrLine>Campus Universitaire de Beaulieu - Bât 22 - 35042 Rennes</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.ltsi.univ-rennes1.fr</ref>
</desc>
<listRelation>
<relation active="#struct-105160" type="direct"></relation>
<relation active="#struct-528860" type="indirect"></relation>
<relation name="U1099" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-105160" type="direct">
<org type="institution" xml:id="struct-105160" status="VALID">
<orgName>Université de Rennes 1</orgName>
<orgName type="acronym">UR1</orgName>
<desc>
<address>
<addrLine>2 rue du Thabor - CS 46510 - 35065 Rennes cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-rennes1.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-528860" type="direct"></relation>
</listRelation>
</org>
</tutelle>
<tutelle active="#struct-528860" type="indirect">
<org type="regroupinstitution" xml:id="struct-528860" status="VALID">
<orgName>Université de Rennes</orgName>
<orgName type="acronym">UNIV-RENNES</orgName>
<date type="start">2018-01-01</date>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle name="U1099" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:tel-01156546</idno>
<idno type="halId">tel-01156546</idno>
<idno type="halUri">https://tel.archives-ouvertes.fr/tel-01156546</idno>
<idno type="url">https://tel.archives-ouvertes.fr/tel-01156546</idno>
<date when="2014-06-17">2014-06-17</date>
<idno type="wicri:Area/Hal/Corpus">000033</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Atrial Fibrillation : from pathophysiology to therapy</title>
<title xml:lang="fr">Fibrillation atriale : des mécanismes physiopathologiques à la prise en charge thérapeutique</title>
<author>
<name sortKey="Martins, Pedro Raphael" sort="Martins, Pedro Raphael" uniqKey="Martins P" first="Pedro Raphaël" last="Martins">Pedro Raphaël Martins</name>
<affiliation>
<hal:affiliation type="laboratory" xml:id="struct-182223" status="VALID">
<orgName>Laboratoire Traitement du Signal et de l'Image</orgName>
<orgName type="acronym">LTSI</orgName>
<desc>
<address>
<addrLine>Campus Universitaire de Beaulieu - Bât 22 - 35042 Rennes</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.ltsi.univ-rennes1.fr</ref>
</desc>
<listRelation>
<relation active="#struct-105160" type="direct"></relation>
<relation active="#struct-528860" type="indirect"></relation>
<relation name="U1099" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-105160" type="direct">
<org type="institution" xml:id="struct-105160" status="VALID">
<orgName>Université de Rennes 1</orgName>
<orgName type="acronym">UR1</orgName>
<desc>
<address>
<addrLine>2 rue du Thabor - CS 46510 - 35065 Rennes cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-rennes1.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-528860" type="direct"></relation>
</listRelation>
</org>
</tutelle>
<tutelle active="#struct-528860" type="indirect">
<org type="regroupinstitution" xml:id="struct-528860" status="VALID">
<orgName>Université de Rennes</orgName>
<orgName type="acronym">UNIV-RENNES</orgName>
<date type="start">2018-01-01</date>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle name="U1099" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
</affiliation>
</author>
</analytic>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="mix" xml:lang="en">
<term>Anti-Arhythmic drug</term>
<term>Atrial fibrillation</term>
<term>Cryoablation</term>
<term>Dominant frequency</term>
<term>Treatment</term>
</keywords>
<keywords scheme="mix" xml:lang="fr">
<term>Anti-Arythmique</term>
<term>Fibrillation atriale</term>
<term>Fréquence dominante</term>
<term>Rotor</term>
<term>Traitement</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Atrial fibrillation (AF) is the most common sustained arrhythmia, significantly increasing patients’ morbidity and mortality. The mechanisms explaining the initiation and maintenance of the arrhythmia are incompletely understood, and the current treatment strategy is suboptimal. To better understand the pathophysiology of AF, we conducted various projects using Langendorff-perfused sheep hearts and a chronic model of long-standing persistent AF. In the model of persistent AF, we demonstrated that dominant frequency (DF) progressively increases during the first weeks of the arrhythmia, during its paroxysmal stage, due to the electrophysiological remodeling resulting in atrial action potential shortening. DF stabilizes once the electrophysiological remodeling is maximal, and the arrhythmia becomes persitent. The rate of DF increase (dDF/dt) was strongly correlated with the time to persistent AF. Structural remodeling appears secondarily, once transition has occured. We also studied the anti-arrhythmic mechanisms of chloroquine (IK1 blocker) and ranolazine (INa blocker), which slow the frequency of rotation of rotors, decrease the DF and favor reversal to sinus rhythm. These projects helped us to better understand the importance of these currents in AF dynamics. Lastly, we demonstrated the increased efficacy of AF ablation when using the second generation cryoballoon (CB), which regrettably increases the occurrence of phrenic nerve palsy. A simple, reliable predictor of this complication was found, the distance between the lateral edge of the CB and the phrenic nerve stimulating catheter. A better understanding of the mechanisms underlying the initiation and maintenance of AF, in conjunction with better therapeutic strategies will help to improve patients’ quality of life and decrease the complications of the arrhythmia.</p>
</div>
</front>
</TEI>
<hal api="V3">
<titleStmt>
<title xml:lang="en">Atrial Fibrillation : from pathophysiology to therapy</title>
<title xml:lang="fr">Fibrillation atriale : des mécanismes physiopathologiques à la prise en charge thérapeutique</title>
<author role="aut">
<persName>
<forename type="first">Pedro Raphaël</forename>
<surname>Martins</surname>
</persName>
<idno type="halauthorid">1170020</idno>
<affiliation ref="#struct-182223"></affiliation>
</author>
<editor role="depositor">
<persName>
<forename>ABES</forename>
<surname>STAR</surname>
</persName>
<email type="md5">f5aa7f563b02bb6adbba7496989af39a</email>
<email type="domain">abes.fr</email>
</editor>
</titleStmt>
<editionStmt>
<edition n="v1" type="current">
<date type="whenSubmitted">2015-05-27 15:27:05</date>
<date type="whenModified">2018-05-16 11:23:41</date>
<date type="whenReleased">2015-05-28 09:34:55</date>
<date type="whenProduced">2014-06-17</date>
<date type="whenEndEmbargoed">2015-05-27</date>
<ref type="file" target="https://tel.archives-ouvertes.fr/tel-01156546/document">
<date notBefore="2015-05-27"></date>
</ref>
<ref type="file" subtype="author" n="1" target="https://tel.archives-ouvertes.fr/tel-01156546/file/martins_pedrofacile.pdf">
<date notBefore="2015-05-27"></date>
</ref>
</edition>
<respStmt>
<resp>contributor</resp>
<name key="131274">
<persName>
<forename>ABES</forename>
<surname>STAR</surname>
</persName>
<email type="md5">f5aa7f563b02bb6adbba7496989af39a</email>
<email type="domain">abes.fr</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt>
<distributor>CCSD</distributor>
<idno type="halId">tel-01156546</idno>
<idno type="halUri">https://tel.archives-ouvertes.fr/tel-01156546</idno>
<idno type="halBibtex">martins:tel-01156546</idno>
<idno type="halRefHtml">Cardiologie et système cardiovasculaire. Université Rennes 1, 2014. Français. ⟨NNT : 2014REN1B010⟩</idno>
<idno type="halRef">Cardiologie et système cardiovasculaire. Université Rennes 1, 2014. Français. ⟨NNT : 2014REN1B010⟩</idno>
</publicationStmt>
<seriesStmt>
<idno type="stamp" n="STAR">STAR - Dépôt national des thèses électroniques</idno>
<idno type="stamp" n="UNIV-RENNES1">Université de Rennes 1</idno>
<idno type="stamp" n="LTSI" corresp="INSERM">Laboratoire Traitement du Signal et de l'Image</idno>
<idno type="stamp" n="INSERM">INSERM - Institut national de la santé et de la recherche médicale</idno>
<idno type="stamp" n="UR1-THESES" corresp="UNIV-RENNES1">Thèses de l'Université de Rennes 1</idno>
<idno type="stamp" n="UR1-MATH-STIC">UR1 - publications Maths-STIC</idno>
<idno type="stamp" n="UR1-HAL">Publications labos UR1 dans HAL-Rennes 1</idno>
<idno type="stamp" n="CARDIO" corresp="INSERM">Cardiovasculaire</idno>
<idno type="stamp" n="TEST-UNIV-RENNES">TEST Université de Rennes</idno>
<idno type="stamp" n="TEST-UR-CSS">TEST Université de Rennes CSS</idno>
<idno type="stamp" n="UNIV-RENNES">Université de Rennes</idno>
</seriesStmt>
<notesStmt></notesStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Atrial Fibrillation : from pathophysiology to therapy</title>
<title xml:lang="fr">Fibrillation atriale : des mécanismes physiopathologiques à la prise en charge thérapeutique</title>
<author role="aut">
<persName>
<forename type="first">Pedro Raphaël</forename>
<surname>Martins</surname>
</persName>
<idno type="halauthorid">1170020</idno>
<affiliation ref="#struct-182223"></affiliation>
</author>
</analytic>
<monogr>
<idno type="nnt">2014REN1B010</idno>
<imprint>
<date type="dateDefended">2014-06-17</date>
</imprint>
<authority type="institution">Université Rennes 1</authority>
<authority type="school">École doctorale Vie-Agro-Santé (Rennes)</authority>
<authority type="supervisor">Philippe Mabo</authority>
</monogr>
</biblStruct>
</sourceDesc>
<profileDesc>
<langUsage>
<language ident="fr">French</language>
</langUsage>
<textClass>
<keywords scheme="author">
<term xml:lang="en">Cryoablation</term>
<term xml:lang="en">Atrial fibrillation</term>
<term xml:lang="en">Dominant frequency</term>
<term xml:lang="en">Anti-Arhythmic drug</term>
<term xml:lang="en">Treatment</term>
<term xml:lang="fr">Fréquence dominante</term>
<term xml:lang="fr">Rotor</term>
<term xml:lang="fr">Fibrillation atriale</term>
<term xml:lang="fr">Traitement</term>
<term xml:lang="fr">Anti-Arythmique</term>
</keywords>
<classCode scheme="halDomain" n="sdv.mhep.csc">Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system</classCode>
<classCode scheme="halTypology" n="THESE">Theses</classCode>
</textClass>
<abstract xml:lang="en">
<p>Atrial fibrillation (AF) is the most common sustained arrhythmia, significantly increasing patients’ morbidity and mortality. The mechanisms explaining the initiation and maintenance of the arrhythmia are incompletely understood, and the current treatment strategy is suboptimal. To better understand the pathophysiology of AF, we conducted various projects using Langendorff-perfused sheep hearts and a chronic model of long-standing persistent AF. In the model of persistent AF, we demonstrated that dominant frequency (DF) progressively increases during the first weeks of the arrhythmia, during its paroxysmal stage, due to the electrophysiological remodeling resulting in atrial action potential shortening. DF stabilizes once the electrophysiological remodeling is maximal, and the arrhythmia becomes persitent. The rate of DF increase (dDF/dt) was strongly correlated with the time to persistent AF. Structural remodeling appears secondarily, once transition has occured. We also studied the anti-arrhythmic mechanisms of chloroquine (IK1 blocker) and ranolazine (INa blocker), which slow the frequency of rotation of rotors, decrease the DF and favor reversal to sinus rhythm. These projects helped us to better understand the importance of these currents in AF dynamics. Lastly, we demonstrated the increased efficacy of AF ablation when using the second generation cryoballoon (CB), which regrettably increases the occurrence of phrenic nerve palsy. A simple, reliable predictor of this complication was found, the distance between the lateral edge of the CB and the phrenic nerve stimulating catheter. A better understanding of the mechanisms underlying the initiation and maintenance of AF, in conjunction with better therapeutic strategies will help to improve patients’ quality of life and decrease the complications of the arrhythmia.</p>
</abstract>
<abstract xml:lang="fr">
<p>La fibrillation atriale (FA) est l’arythmie soutenue la plus fréquente ; elle entraine une majoration significative de la morbidité et de la mortalité. Les mécanismes qui en sont responsables sont encore incomplètement connus, et sa prise en charge n’est pas optimale. Afin de mieux comprendre la physiopathologie de la FA, nous avons mené différents travaux sur des coeurs de moutons isolés et perfusés par un système de Langendorff mais également en créant un modèle chronique de FA persistante de longue durée. Dans un modèle ovin de FA persistante, nous avons ainsi démontré que la fréquence dominante (DF) de la FA augmentait progressivement pendant les premières semaines de l’arythmie, alors que les épisodes étaient paroxystiques, phénomène en rapport avec le raccourcissement de la durée du potentiel d’action secondaire au remodelage électrophysiologique. La DF se stabilisait dès lors que la FA devenait persistante, une fois le remodelage électrophysiologique maximal. L’accélération de la DF (dDF/dt) était significativement corrélée au temps nécessaire à la transition vers la FA persistante. Le remodelage structurel n’apparaissait que secondairement, une fois l’arythmie devenue persistante. Sur le plan thérapeutique, nous avons étudié les mécanismes anti-arythmiques de la chloroquine (bloqueur d’IK1) et de la ranolazine (bloqueur d’INa), molécules entrainant un ralentissement de la fréquence de rotation des rotors, une diminution de la DF et un retour en rythme sinusal. Ces travaux nous ont permis de mieux appréhender le rôle des ces courants ioniques dans le maintien de la FA. Enfin, nous avons démontré l’efficacité de l’ablation de la FA en utilisant le cryoballon (CB) de deuxième génération, efficacité grevée d’un taux de parésie du nerf phrénique élevé, dont nous avons pu prédire la survenue à l’aide d’un prédicteur simple, la distance entre le bord du CB et la cathéter permettant de stimuler le nerf phrénique pendant l’application. Une meilleure compréhension des mécanismes à l’origine de l’initiation et du maintien de cette arythmie, ainsi qu’une meilleure prise en charge thérapeutique permettraient d’améliorer la qualité de vie des patients et d’en diminuer le taux de complications.</p>
</abstract>
</profileDesc>
</hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Hal/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000033 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Hal/Corpus/biblio.hfd -nk 000033 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Hal
   |étape=   Corpus
   |type=    RBID
   |clé=     Hal:tel-01156546
   |texte=   Atrial Fibrillation : from pathophysiology to therapy
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021